Alltrna Appoints Dr. Nerissa Kreher as Chief Medical Officer to Advance TRNA Medicines for Rare Diseases

PR NewswireJan 6 21:00

Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 18, 2024 20:00

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16, 2024 22:56

Are Strong Financial Prospects The Force That Is Driving The Momentum In Entrada Therapeutics, Inc.'s NASDAQ:TRDA) Stock?

Simply Wall StDec 13, 2024 18:00

Roth MKM Starts 'Overlooked' Entrada Therapeutics With Buy Rating

Yahoo FinanceDec 7, 2024 18:25

Roth Initiates Entrada Therapeutics at Buy

MT NewswiresDec 6, 2024 21:08